Amendment H-8022 to HF 2492
Relating to insurance coverage for biomarker testing
Never voted on
Filed February 19, 2024 in the House by
What it changes
- Page 1, by striking lines 14 through 17 and inserting: “c. “Clinical utility” means the test result provides information that is used in the formulation of a treatment or monitoring strategy that informs a patient’s outcome and impacts the clinical decision.”
- Page 2, line 8, by striking “costs” and inserting “risks”